Cargando…
Ultrasound Enhanced Delivery of Molecular Imaging and Therapeutic Agents in Alzheimer's Disease Mouse Models
Alzheimer's disease is a neurodegenerative disorder typified by the accumulation of a small protein, beta-amyloid, which aggregates and is the primary component of amyloid plaques. Many new therapeutic and diagnostic agents for reducing amyloid plaques have limited efficacy in vivo because of p...
Autores principales: | Raymond, Scott B., Treat, Lisa H., Dewey, Jonathan D., McDannold, Nathan J., Hynynen, Kullervo, Bacskai, Brian J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364662/ https://www.ncbi.nlm.nih.gov/pubmed/18478109 http://dx.doi.org/10.1371/journal.pone.0002175 |
Ejemplares similares
-
5th International Symposium on Therapeutic Ultrasound
por: Clement, G T, et al.
Publicado: (2006) -
“Non-thermal” ablation using focused ultrasound and an ultrasound contrast agent
por: McDannold, Nathan
Publicado: (2015) -
Therapeutic effects of focused ultrasound-mediated blood-brain barrier opening in a mouse model of Alzheimer’s disease
por: Burgess, Alison, et al.
Publicado: (2015) -
Can ultrasound contrast agents increase the treatment envelope?
por: McDannold, Nathan, et al.
Publicado: (2015) -
Driving Circuitry for Focused Ultrasound Noninvasive Surgery and Drug Delivery Applications
por: El-Desouki, Munir M., et al.
Publicado: (2011)